Drug Shortage Report for LOSARTAN HCT
Report ID | 120609 |
Drug Identification Number | 02388987 |
Brand name | LOSARTAN HCT |
Common or Proper name | LOSARTAN HCT |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | DORMANT |
Active Ingredient(s) | LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE |
Strength(s) | 100MG 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-03-15 |
Actual start date | |
Estimated end date | 2021-04-05 |
Actual end date | 2021-03-22 |
Shortage status | Resolved |
Updated date | 2021-03-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-07-17 | French | Compare |
v1 | 2020-07-17 | English | Compare |